Sandoz Bolsters US Ophthalmic Portfolio With Aflibercept Approval

Launch Date Of Eylea Biosimilar Uncertain As ‘Complicated’ Court Proceedings Continue

 
• By Dave Wallace
  
USA flag reflected in eye
Sandoz has received FDA approval for its Enzeevu rival to Eylea • Source: Shutterstock

More from Biosimilars

More from Products